Klaus Dalhoff

7.2k citations

141 papers · 4.2k indexed · h-index 37

Impact in

Microbiology top 0.5%
- Reproductive tract infections research
Immunology top 2%
- Immune Response and Inflammation

Papers in ⓘ

Microbiology 18
- Reproductive tract infections research 17
Epidemiology 72
- Pneumonia and Respiratory Infections 34
- Pneumocystis jirovecii pneumonia detection and treatment 17
- Respiratory viral infections research 15

Co-authors: Matthias Maass (16 shared papers)P. Zabel (21 shared papers)Daniel Droemann (14 shared papers)Bernhard Schaaf (22 shared papers)Torsten Goldmann (16 shared papers)Jan Rupp (23 shared papers)H. Kothe (13 shared papers)Ekkehard Vollmer (6 shared papers)
Journals: European Respiratory Journal (10 papers)Respiration (6 papers)American Journal of Respiratory and Critical Care Medicine (4 papers)Respiratory Research (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

Klaus Dalhoff

130 papers receiving 4.0k citations

Peers

Countries citing papers authored by Klaus Dalhoff

Since Specialization

Citations

This map shows the geographic impact of Klaus Dalhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Dalhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Dalhoff more than expected).

Fields of papers citing papers by Klaus Dalhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Dalhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Dalhoff. The network helps show where Klaus Dalhoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Klaus Dalhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Klaus Dalhoff Line = papers co-authored together Klaus Dalhoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Human lung cancer cells express functionally active Toll-like receptor 9 Respiratory Research ·Daniel Droemann, D. Albrecht, Johannes Gerdes, Artur J. Ulmer, D. Branscheid, Ekkehard Vollmer, Klaus Dalhoff, P. Zabel, Torsten Goldmann	2005	288
2	Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients Respiratory Research ·Daniel Droemann, Torsten Goldmann, T Tiedje, P. Zabel, Klaus Dalhoff, Bernhard Schaaf	2005	182
3	Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment Circulation ·Jens Gieffers, Henriette Füllgraf, Jürgen Jahn, Matthias Klinger, Klaus Dalhoff, Hugo A. Katus, Werner Solbach, Matthias Maass	2001	178
4	Pentoxifylline in Treatment of Sarcoidosis American Journal of Respiratory and Critical Care Medicine ·P. Zabel, P. Entzian, Klaus Dalhoff, Max Schlaak	1997	149
5	Pneumococcal Septic Shock Is Associated with the Interleukin-10–1082 Gene Promoter Polymorphism American Journal of Respiratory and Critical Care Medicine ·Bernhard Schaaf, Florian Boehmke, Hamed Esnaashari, Ulrike Seitzer, H. Kothe, Matthias Maass, P. Zabel, Klaus Dalhoff	2003	141
6	Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment European Respiratory Journal ·H. Kothe, Torsten Bauer, R. Marre, Norbert Suttorp, Tobias Welte, Klaus Dalhoff, (unknown)	2008	136
7	Chlamydia pneumoniae Multiply in Neutrophil Granulocytes and Delay Their Spontaneous Apoptosis The Journal of Immunology ·Ger van Zandbergen, Jens Gieffers, H. Kothe, Jan Rupp, Annalena Bollinger, Eresso Aga, Matthias Klinger, Helmut Brade, Klaus Dalhoff, Matthias Maass, Werner Solbach, Tamás Laskay	2004	126
8	E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: A randomized, double-blinded pilot study Vascular Medicine ·Klaas Franzen, Johannes Willig, Silja Cayo Talavera, Moritz Meusel, Friedhelm Sayk, Michael Reppel, Klaus Dalhoff, Kai Mortensen, Daniel Droemann	2018	124
9	Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory Response of Human Macrophages and Endothelial Cells Infected With Chlamydia pneumoniae Circulation ·H. Kothe, Klaus Dalhoff, Jan Rupp, Angélica Müller, J. Kreuzer, Matthias Maass, Hugo A. Katus	2000	121
10	Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung Histochemistry and Cell Biology ·Daniel Droemann, Torsten Goldmann, D. Branscheid, Ryan R. Clark, Klaus Dalhoff, P. Zabel, Ekkehard Vollmer	2003	109
11	Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – Update 2016 Pneumologie ·Santiago Ewig, G. Höffken, Winfried V. Kern, Gernot Rohde, Holger Flick, Robert Krause, Sebastian R. Ott, Torsten Bauer, Klaus Dalhoff, Sören Gatermann, Martin Kolditz, Stefan Krüger, J. Lorenz, Mathias W. Pletz, A de Roux, Beate Schaaf, T. Schaberg, Hartwig Schütte, Tobias Welte	2016	105
12	Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission The American Journal of Gastroenterology ·Klaus Herrlinger, Mirja K. Noftz, Klaus Dalhoff, D Ludwig, Eduard F. Stange, Klaus Fellermann	2002	100
13	Interaction of Chlamydia pneumoniae and Human Alveolar Macrophages: Infection and Inflammatory Response American Journal of Respiratory Cell and Molecular Biology ·Vanessa Redecke, Klaus Dalhoff, Sabine Bohnet, Jörg Braun, Matthias Maass	1998	94
14	Efficacy of transbronchial biopsy in pulmonary vaculitides European Respiratory Journal ·A. Schnabel, Konstanze Holl‐Ulrich, Klaus Dalhoff, M. Reuter, Gross Wl	1997	82
15	Acute Renal Failure Associated with Tenofovir Treatment in a Patient with Acquired Immunodeficiency Syndrome Clinical Infectious Diseases ·Bernhard Schaaf, Sven Philip Aries, Evelyn Kramme, J. Steinhoff, Klaus Dalhoff	2003	82
16	Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study Group Journal of Clinical Oncology ·Eckart Laack, N. Dickgreber, Thomas Müller, Alexander Knuth, J Benk, Christian Lorenz, Frank Gieseler, Heinz Dürk, Walburga Engel-Riedel, Klaus Dalhoff, C. Kortsik, Ullrich Graeven, M. Burk, T. Dierlamm, Tobias Welte, Iris Burkholder, Lutz Edler, D Hossfeld	2004	71
17	Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease Atherosclerosis ·Matthias Maass, Claus Bartels, Stefan Krüger, E. Tobias Krause, Peter M. Engel, Klaus Dalhoff	1998	69
18	Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009 Pneumologie ·G. Höffken, J. Lorenz, Winfried V. Kern, Tobias Welte, Torsten T. Bauer, Klaus Dalhoff, Eva Susanne Dietrich, Santiago Ewig, Petra Gastmeier, Béatrice Grabein, E Halle, Martin Kolditz, R. Marre, H. Sitter	2009	63
19	Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression Journal of Molecular Medicine ·Sven Philip Aries, Bernhard Schaaf, C. M�ller, Klaus Dalhoff, Reinhard H. Dennin	1995	62
20	Detection ofChlamydia pneumoniaewithin Peripheral Blood Monocytes of Patients with Unstable Angina or Myocardial Infarction The Journal of Infectious Diseases ·Matthias Maass, Jürgen Jahn, Jens Gieffers, Klaus Dalhoff, Hugo A. Katus, Werner Solbach	2000	59

About Klaus Dalhoff

Klaus Dalhoff is a scholar working on Microbiology, Epidemiology, Emergency Medical Services, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 141 papers that have together received 4.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (34 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers), Reproductive tract infections research (17 papers), Immune Response and Inflammation (17 papers), Respiratory viral infections research (15 papers), Pediatric health and respiratory diseases (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Neonatal Respiratory Health Research (12 papers). The work is most often cited by research in Microbiology (666 citations), Immunology (1.1k citations), Critical Care and Intensive Care Medicine (232 citations), Epidemiology (1.5k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Klaus Dalhoff has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Matthias Maass, P. Zabel, Daniel Droemann, Bernhard Schaaf, Torsten Goldmann, Jan Rupp, H. Kothe, Ekkehard Vollmer, Hugo A. Katus and Jörg Braun. Their work appears in journals such as European Respiratory Journal, Respiration, American Journal of Respiratory and Critical Care Medicine, Respiratory Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact